在加拿大魁北克引起侵袭性脑膜炎球菌病的C群ET-15脑膜炎球菌独特变体（抗原公式为C:2a:P1.7,1）的表型和基因特征
Phenotypic and genetic characterization of a unique variant of serogroup C ET-15 meningococci (with the antigenic formula C:2a:P1.7,1) causing invasive meningococcal disease in Quebec, Canada.
作者信息
Tsang Raymond S W, Tsai Chao Ming, Zhu Peixuan, Ringuette Louise, Lorange Manon, Law Dennis K S
机构信息
CNS Infection Division, National Microbiology Laboratory, Health Canada, Winnipeg, Manitoba.
出版信息
J Clin Microbiol. 2004 Apr;42(4):1460-5. doi: 10.1128/JCM.42.4.1460-1465.2004.
Abstract
Serogroup C Neisseria meningitidis belonging to the electrophoretic type (ET) ET-15, a variant of ET-37, is endemic in Canada. Like other serogroup C ET-37 meningococci, the endemic ET-15 strains are usually found to carry the serotype and serosubtype antigens of 2a:P1.5,2. In 2001, a sudden increase in the number of cases of serogroup C meningococcal disease in Quebec, Canada, was caused by an antigenic variant of the ET-15 strain. This antigenic variant carries the unique serosubtype marker of P1.7,1. Strains of C:2a:P1.7,1 meningococci were not isolated in Canada in large numbers prior to 2001, and the characteristics of these meningococcal strains linked to an outbreak in Quebec, Canada, are described in the present study.
摘要
属于电泳型（ET）ET-15（ET-37的一个变体）的C群脑膜炎奈瑟菌在加拿大呈地方性流行。与其他C群ET-37脑膜炎球菌一样，地方性流行的ET-15菌株通常携带2a:P1.5,2的血清型和血清亚型抗原。2001年，加拿大魁北克省C群脑膜炎球菌病病例数突然增加，是由ET-15菌株的一种抗原变体引起的。这种抗原变体携带独特的P1.7,1血清亚型标记。2001年之前，C:2a:P1.7,1脑膜炎球菌菌株在加拿大未大量分离，本研究描述了与加拿大魁北克省一次暴发相关的这些脑膜炎球菌菌株的特征。
相似文献
1
Phenotypic and genetic characterization of a unique variant of serogroup C ET-15 meningococci (with the antigenic formula C:2a:P1.7,1) causing invasive meningococcal disease in Quebec, Canada.
J Clin Microbiol. 2004 Apr;42(4):1460-5. doi: 10.1128/JCM.42.4.1460-1465.2004.
2
Antigenic and genetic characterization of serogroup C meningococci isolated from invasive meningococcal disease cases in Canada from 1999 to 2003.
Can J Microbiol. 2005 Jul;51(7):523-30. doi: 10.1139/w05-085.
3
Characterization of Neisseria meningitidis strains isolated from invasive meningococcal disease cases in Canada in 2001.
Can J Microbiol. 2003 Oct;49(10):633-8. doi: 10.1139/w03-074.
4
Increase in serogroup C meningococcal disease in Canada is associated with antigenic changes in the protein antigens of the ET-15 clone of Neisseria meningitidis.
J Infect Dis. 2006 Dec 15;194(12):1791-2; author reply 1792-3. doi: 10.1086/509515.
5
Genetic and antigenic characterization of Canadian invasive Neisseria meningitidis serogroup C (MenC) case isolates in the post-MenC conjugate vaccine era, 2009-2013.
J Med Microbiol. 2015 Feb;64(Pt 2):174-9. doi: 10.1099/jmm.0.000006-0.
6
Outbreak of meningococcal disease caused by PorA-deficient meningococci.
J Infect Dis. 2003 Mar 1;187(5):869-71. doi: 10.1086/367899. Epub 2003 Feb 18.
7
Genetic and antigenic analysis of invasive serogroup Y Neisseria meningitidis isolates collected from 1999 to 2003 in Canada.
J Clin Microbiol. 2007 Jun;45(6):1753-8. doi: 10.1128/JCM.02134-06. Epub 2007 Apr 18.
8
PorA variable antigenic regions VR1, VR2, and VR3 of Neisseria meningitidis serogroups B and C isolated in Brazil from 1999 to 2004.
Infect Immun. 2007 Jul;75(7):3683-5. doi: 10.1128/IAI.01721-06. Epub 2007 May 14.
9
Clonal distribution of invasive Neisseria meningitidis serogroup C strains circulating from 1976 to 2005 in greater Sao Paulo, Brazil.
J Clin Microbiol. 2007 Apr;45(4):1266-73. doi: 10.1128/JCM.02510-06. Epub 2007 Feb 21.
10
Genome-based study of a spatio-temporal cluster of invasive meningococcal disease due to Neisseria meningitidis serogroup C, clonal complex 11.
J Infect. 2016 Aug;73(2):136-44. doi: 10.1016/j.jinf.2016.05.003. Epub 2016 May 24.
引用本文的文献
1
Characterisation of Neisseria meningitidis cc11/ET-15 variant by whole genome sequencing.
Mem Inst Oswaldo Cruz. 2022 Oct 7;117:e220118. doi: 10.1590/0074-02760220118. eCollection 2022.
2
Genetic and antigenic analysis of invasive serogroup C Neisseria meningitidis in Canada: A decrease in the electrophoretic type (ET)-15 clonal type and an increase in the proportion of isolates belonging to the ET-37 (but not ET-15) clonal type during the period from 2002 to 2009.
Can J Infect Dis Med Microbiol. 2012 Fall;23(3):e55-9. doi: 10.1155/2012/131328.
3
The changing epidemiology of meningococcal disease in Quebec, Canada, 1991-2011: potential implications of emergence of new strains.
PLoS One. 2012;7(11):e50659. doi: 10.1371/journal.pone.0050659. Epub 2012 Nov 29.
4
Invasive serogroup B Neisseria meningitidis in Quebec, Canada, 2003 to 2010: persistence of the ST-269 clone since it first emerged in 2003.
J Clin Microbiol. 2012 May;50(5):1545-51. doi: 10.1128/JCM.06835-11. Epub 2012 Feb 15.
5
Meningococcal disease: shifting epidemiology and genetic mechanisms that may contribute to serogroup C virulence.
Curr Infect Dis Rep. 2011 Aug;13(4):374-9. doi: 10.1007/s11908-011-0195-7.
6
A generic mechanism in Neisseria meningitidis for enhanced resistance against bactericidal antibodies.
J Exp Med. 2008 Jun 9;205(6):1423-34. doi: 10.1084/jem.20072577. Epub 2008 May 26.
7
Analysis of phenotypic variants of the serogroup C ET-15 clone of Neisseria meningitidis by pulsed-field gel electrophoresis.
J Clin Microbiol. 2007 Jul;45(7):2351-2. doi: 10.1128/JCM.00908-07. Epub 2007 May 9.
8
Invasive meningococcal disease in Quebec, Canada, due to an emerging clone of ST-269 serogroup B meningococci with serotype antigen 17 and serosubtype antigen P1.19 (B:17:P1.19).
J Clin Microbiol. 2006 Aug;44(8):2743-9. doi: 10.1128/JCM.00601-06.
9
DNA Sequence analysis of the PorB protein of nonserotypeable serogroup C ET-15 meningococci suggests a potential mutational hot spot on their serotype antigens.
J Clin Microbiol. 2004 Jun;42(6):2718-23. doi: 10.1128/JCM.42.6.2718-2723.2004.
本文引用的文献
1
Serological characterization.
Methods Mol Med. 2001;67:131-45. doi: 10.1385/1-59259-149-3:131.
2
Distribution of serogroups of Neisseria meningitidis and antigenic characterization of serogroup Y meningococci in Canada, January 1, 1999 to June 30, 2001.
Can J Infect Dis. 2002 Nov;13(6):391-6. doi: 10.1155/2002/891673.
3
Characterization of Neisseria meningitidis strains isolated from invasive meningococcal disease cases in Canada in 2001.
Can J Microbiol. 2003 Oct;49(10):633-8. doi: 10.1139/w03-074.
4
Outbreak of serogroup C meningococcal disease caused by a variant of Neisseria meningitidis serotype 2a ET-15 in a community of men who have sex with men.
J Clin Microbiol. 2003 Sep;41(9):4411-4. doi: 10.1128/JCM.41.9.4411-4414.2003.
5
Meningococcal disease among United States military service members in relation to routine uses of vaccines with different serogroup-specific components, 1964-1998.
Clin Infect Dis. 2002 Dec 1;35(11):1376-81. doi: 10.1086/344273. Epub 2002 Nov 5.
6
Genetic diversity of three lgt loci for biosynthesis of lipooligosaccharide (LOS) in Neisseria species.
Microbiology (Reading). 2002 Jun;148(Pt 6):1833-1844. doi: 10.1099/00221287-148-6-1833.
7
Outbreak of Neisseria meningitidis, Edmonton, Alberta, Canada.
Emerg Infect Dis. 2002 May;8(5):519-21. doi: 10.3201/eid0805.010337.
8
An Advisory Committee Statement (ACS). Statement on recommended use of meningococcal vaccines.
Can Commun Dis Rep. 2001 Oct 15;27:2-36.
9
The panmictic nature of Neisseria meningitidis serogroup B during a period of endemic disease in Canada.
Can J Microbiol. 2001 Apr;47(4):283-9.
10
Effectiveness of a mass immunization campaign against serogroup C meningococcal disease in Quebec.
JAMA. 2001 Jan 10;285(2):177-81. doi: 10.1001/jama.285.2.177.
Zotero 插件